Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin for recovery after traumatic brain injury
ISRCTN17097163Phase 4Completed
- Sponsor
- EN: The foundation for the study of neuroscience and reuroregeneration (RO: Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii)
- Start
- Apr 2013
- Modality
- Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Native Peptides → Peptides, Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cerebrolysin in traumatic brain injury (TBI) (2 arms), sponsored by EN: The foundation for the study of neuroscience and reuroregeneration (RO: Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii). Primary endpoints: Processing Speed Index at day 90, Stroop Color-Word Test – Victoria Version at day 90 and 7 more. Started Apr 2013; status: completed.
02
Drugs
cerebrolysin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ISRCTN17097163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17097163.